{{Rsnum
|rsid=10871290
|Chromosome=16
|position=74438798
|Orientation=plus
|GMAF=0.3756
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 40.7 | 46.9
| HCB | 8.0 | 53.3 | 38.7
| JPT | 13.3 | 45.1 | 41.6
| YRI | 27.9 | 45.6 | 26.5
| ASW | 28.1 | 36.8 | 35.1
| CHB | 8.0 | 53.3 | 38.7
| CHD | 18.3 | 40.4 | 41.3
| GIH | 5.0 | 34.7 | 60.4
| LWK | 24.5 | 45.5 | 30.0
| MEX | 8.6 | 20.7 | 70.7
| MKK | 30.1 | 51.9 | 17.9
| TSI | 13.7 | 50.0 | 36.3
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10871290
|PubMedID=18463975
|Condition=Breast cancer
|Gene=GLG1
|Risk Allele=
|pValue=4.00E-007
|OR=NA
|95CI=
}}

{{PharmGKB
|RSID=rs10871290
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18463975; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A pilot genome-wide association study of early-onset breast cancer (Initial Sample Size: 30 cases, 30 controls; Replication Sample Size: NR). This variant is associated with Breast cancer.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356396
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10871290
|overall_frequency_n=75
|overall_frequency_d=120
|overall_frequency=0.625
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=66
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}